Literature DB >> 12431721

Malnutrition is a risk factor in cirrhotic patients undergoing surgery.

Manuela Merli1, Giorgia Nicolini, Stefania Angeloni, Oliviero Riggio.   

Abstract

Cirrhotic patients may become candidates for elective and emergency surgery. This may be due to conditions requiring operations such as cholecystectomy, herniotomy, or gastrointestinal malignancies, more common in cirrhotics when compared with the general population, or to complications of the liver disease such as resectable hepatocellular carcinomas or surgical portosystemic shunts to treat portal hypertension. It has been estimated that 10% of cirrhotics undergo at least one operative procedure during the final 2 y of their lives. Many studies have documented a high risk of morbidity and mortality associated with surgical procedures in these patients, and several factors influencing the postoperative outcome have been identified. Malnutrition, which is frequently encountered in cirrhotic patients, has been shown to have an important impact on the surgical risk. A poor nutrition status also has been associated with a higher risk of complications and mortality in patients undergoing liver transplantation. Few data are available concerning the perioperative nutrition support in surgical cirrhotic patients. The results of these studies are sometimes encouraging in reporting that the nutrition therapy may improve the clinical outcome in cirrhotic patients undergoing general surgery and/or liver transplantation. The limited number of patients and their heterogeneity, however, do not allow definitive conclusions, and more research on this issue is needed.

Entities:  

Mesh:

Year:  2002        PMID: 12431721     DOI: 10.1016/s0899-9007(02)00984-x

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  25 in total

Review 1.  Nutritional Intervention in Chronic Liver Failure.

Authors:  Mathias Plauth
Journal:  Visc Med       Date:  2019-08-21

Review 2.  Changes in nutritional status after liver transplantation.

Authors:  Michela Giusto; Barbara Lattanzi; Vincenza Di Gregorio; Valerio Giannelli; Cristina Lucidi; Manuela Merli
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 3.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

4.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

5.  Pre-operative volume rather than area of skeletal muscle is a better predictor for post-operative risks for respiratory complications in living-donor liver transplantation.

Authors:  Yuki Wada; Tamotsu Kamishima; Tsuyoshi Shimamura; Norio Kawamura; Kenichiro Yamashita; Kenneth Sutherland; Hiroshi Takeda
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

Review 6.  Neurological complications post-liver transplantation: impact of nutritional status.

Authors:  Chantal Bemeur
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

7.  Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.

Authors:  Jonathan Montomoli; Peter Holland-Fischer; Giampaolo Bianchi; Henning Grønbaek; Hendrik Vilstrup; Giulio Marchesini; Marco Zoli
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

Review 8.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

9.  Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation.

Authors:  Xin-Hua Zhu; Ya-Fu Wu; Yu-Dong Qiu; Chun-Ping Jiang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 10.  Cause and management of muscle wasting in chronic liver disease.

Authors:  Srinivasan Dasarathy
Journal:  Curr Opin Gastroenterol       Date:  2016-05       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.